Allied Critical Metals Announces Receipt of Environmental Permit for the Borralha Tungsten Project in Portugal
critical-metals-investing Allied Critical Metals Announces Material Increase to Mineral Resource Estimate at Borralha Tungsten Project in Northern Portugal
critical-metals-investing Allied Critical Metals Confirms Ultra High-Grade Tungsten Zone at Borralha with 18.0 m @ 0.85 % WO3 including 4.0 m @ 3.72 % WO3
critical-metals-investing Allied Critical Metals Expands Santa Helena Breccia with 6.0 Metres of 1.02% WO3 Intercept at Borralha
critical-metals-investing Allied Critical Metals Earns Strategic Recognition from idD Portugal Defence - Strengthening Europe's Tungsten Security
critical-metals-investing Allied Critical Metals Announces $10 Million Strategic Non-Brokered Private Placement
critical-metals-investing Allied Critical Metals Expands High Grade Footprint at Borralha Tungsten Project
critical-metals-investing Allied Critical Metals Announces Highlights from the 2023-24 Borralha Drill Program
critical-metals-investing Allied Critical Metals Expands Santa Helena Breccia in Borralha with Long Tungsten Intercepts and Confirms High-Grade Trend
EMP METALS ADVANCES CONSTRUCTION OF PROJECT AURORA DEMONSTRATION PLANT BY COMPLETING INTERIOR FINISHING
FDA Accepts LEQEMBI® IQLIK Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease under Priority Review
FDA Accepts LEQEMBI® IQLIKTM Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease under Priority Review
Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies
